Farah Al Khitan, MD
Interventional Cardiology · Gadsden, ALNPI 1386809176
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,635 of the $11,779 with a category attached, or 73.3%. It is spread thinly across 44 manufacturers, the largest accounting for just 22.5%.
Across 211 payments — averaging $55.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$3K
- Inari Medical, Inc.$2K
- Endologix LLC$2K
- Medtronic$1K
- Stryker$464
- Cvrx, Inc.$430
- plus $3K from 38 others
Across 4 payments — averaging $22,670 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$91K
What the payments were for
- Travel & lodging$3,04426%
- Food & beverage$8,63573%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$2,331
- CT THROMBECTOMY SYSTEM KIT$2,073
- (9520) IGT Devices Undivided$1,586
- ENDOCROSS Device$1,453
- Torus Stent Graft System$1,453
- Barostim Neo System$291
- Impella$256
- VenaSeal$248
- FlowTriever$170
- ONYX FRONTIER$157
- (5050) Extended Holter$152
- MitraClip System$152
- CardioMEMS HF System$143
- LIMFLOW SYSTEM$140
- WATCHMAN Access System$138
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$126
- Turbo Elite$121
- (6582) Visions 035$117
- LINQ II$109
- Lasers$108
How this compares
$11,779 in reported general payments places this provider in the 65th percentile of 109 interventional cardiology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 40 | $36,993 |
| EliquisApixaban | 49 | $35,313 |
| EntrestoSacubitril/Valsartan | 18 | $14,619 |
| Prasugrel Hcl | 13 | $1,232 |
| ClopidogrelClopidogrel Bisulfate | 104 | $720 |
| Atorvastatin Calcium | 33 | $341 |
| Losartan Potassium | 30 | $309 |
| Rosuvastatin Calcium | 24 | $254 |
| Amlodipine Besylate | 34 | $241 |
| Metoprolol Succinate | 19 | $183 |
| Carvedilol | 31 | $163 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 28 | $127 |
| Lisinopril | 17 | $45 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $253 | $36,99340 claims |
| PfizerEliquis | $103 | $35,31349 claims |
| NovartisEntresto | $58 | $14,61918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 109 interventional cardiology providers in Alabama.
Other interventional cardiology in Gadsden
- Sawan JalnapurkarGadsden$24K
- Gary RoubinBirmingham$157K
- Michael ButlerHuntsville$109K
- Pochana ReddyHuntsville$100K
- Robert FosterBirmingham$90K
- Hasan GuvenBirmingham$86K
- John GallaMobile$82K
- Areen Al-TaieFlorence$69K
- Abdullah MahmoodBirmingham$61K
- Ali EbrahimiBirmingham$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.